EJCP is renewing itself—and will soon celebrate its 40th anniversary! Rune DahlqvistSandra Thake Editorial 24 July 2007 Pages: 815 - 815
An in vitro approach to potential methadone metabolic-inhibition interactions Stephanie BomsienGisela Skopp Pharmacokinetics and Disposition 28 June 2007 Pages: 821 - 827
Tolfenamic acid is a potent CYP1A2 inhibitor in vitro but does not interact in vivo: correction for protein binding is needed for data interpretation Marjo J. KarjalainenPertti J. NeuvonenJanne T. Backman Pharmacokinetics and Disposition 06 July 2007 Pages: 829 - 836
Serum and cerebrospinal fluid morphine pharmacokinetics after single doses of intravenous and intramuscular morphine after hip replacement surgery O. DaleJ. ThonerP. Klepstad Pharmacokinetics and Disposition 10 July 2007 Pages: 837 - 842
Prescribing of hormone therapy for menopause, tibolone, and bisphosphonates in women in the UK between 1991 and 2005 Joanna WatsonLesley WiseJane Green Pharmacoepidemiology and Prescription 28 June 2007 Pages: 843 - 849
Potential drug interactions during a three-decade study period: a cross-sectional study of a prescription register Emelie ÅstrandBengt ÅstrandGöran Petersson Pharmacoepidemiology and Prescription 28 June 2007 Pages: 851 - 859
Early discontinuation: more frequent among general practitioners with high levels of prescribing Dorte Gilså HansenAnthony GichangiJohn Larsen Pharmacoepidemiology and Prescription 06 July 2007 Pages: 861 - 865
Benzodiazepine use in the real world of psychiatric practice: low-dose, long-term drug taking and low rates of treatment discontinuation Antonio VeroneseMassimo GarattiCorrado Barbui Pharmacoepidemiology and Prescription 10 July 2007 Pages: 867 - 873
New onset of atrial fibrillation after introduction of azathioprine in ulcerative colitis: case report and review of the literature Andrea CassinottiAlessandro MassariGabriele Bianchi Porro Short Communication 28 June 2007 Pages: 875 - 878
New antirheumatic drugs: any real added value? A critical overview of regulatory criteria for their marketing approval Vittorio Bertele’Alessandro AssisiSilvio Garattini Point of View 24 July 2007 Pages: 879 - 889
Topiramate-induced weight loss is possibly due to the blockade of conditioned and automatic processes Yasser KhazaalDaniele Fabio Zullino Letter to the Editors 14 July 2007 Pages: 891 - 892
About the appetite-related effects of topiramate Angelo TremblayJean-Philippe Chaput Letter to the Editors 14 July 2007 Pages: 893 - 893
Interaction of clozapine and ciprofloxacin: a case report Rajvinder S. SambhiRamneesh PuriGaynor Jones Letter to the Editors 12 July 2007 Pages: 895 - 896